Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance.
Trocchianesi S, Po A, Citarella A, Spinello Z, Rughetti A, Besharat ZM, Autilio TM, Pecce V, Verrienti A, Elisei R, Durante C, Catanzaro G, Ferretti E. Trocchianesi S, et al. Among authors: citarella a. Biomed Pharmacother. 2023 Aug;164:114995. doi: 10.1016/j.biopha.2023.114995. Epub 2023 Jun 8. Biomed Pharmacother. 2023. PMID: 37301138 Free article.
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression.
Catanzaro G, Besharat ZM, Carai A, Jäger N, Splendiani E, Colin C, Po A, Chiacchiarini M, Citarella A, Gianno F, Cacchione A, Miele E, Diomedi Camassei F, Gessi M, Massimi L, Locatelli F, Jones DTW, Figarella-Branger D, Pfister SM, Mastronuzzi A, Giangaspero F, Ferretti E. Catanzaro G, et al. Among authors: citarella a. Biomark Res. 2022 Jun 17;10(1):44. doi: 10.1186/s40364-022-00389-x. Biomark Res. 2022. PMID: 35715818 Free PMC article.
Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy.
Citarella A, Catanzaro G, Besharat ZM, Trocchianesi S, Barbagallo F, Gosti G, Leonetti M, Di Fiore A, Coppola L, Autilio TM, Spinello Z, Vacca A, De Smaele E, Venneri MA, Ferretti E, Masuelli L, Po A. Citarella A, et al. Cancers (Basel). 2023 Feb 25;15(5):1471. doi: 10.3390/cancers15051471. Cancers (Basel). 2023. PMID: 36900263 Free PMC article.
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
Besharat ZM, Trocchianesi S, Verrienti A, Ciampi R, Cantara S, Romei C, Sabato C, Noviello TMR, Po A, Citarella A, Caruso FP, Panariello I, Gianno F, Carpino G, Gaudio E, Chiacchiarini M, Masuelli L, Sponziello M, Pecce V, Ramone T, Maino F, Dotta F, Ceccarelli M, Pezzullo L, Durante C, Castagna MG, Elisei R, Ferretti E. Besharat ZM, et al. Among authors: citarella a. J Endocrinol Invest. 2023 Dec;46(12):2583-2599. doi: 10.1007/s40618-023-02115-2. Epub 2023 Jun 7. J Endocrinol Invest. 2023. PMID: 37286863 Free PMC article.
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
Besharat ZM, Trocchianesi S, Verrienti A, Ciampi R, Cantara S, Romei C, Sabato C, Noviello TMR, Po A, Citarella A, Caruso FP, Panariello I, Gianno F, Carpino G, Gaudio E, Chiacchiarini M, Masuelli L, Sponziello M, Pecce V, Ramone T, Maino F, Dotta F, Ceccarelli M, Pezzullo L, Durante C, Castagna MG, Elisei R, Ferretti E. Besharat ZM, et al. Among authors: citarella a. J Endocrinol Invest. 2024 Feb;47(2):485. doi: 10.1007/s40618-023-02172-7. J Endocrinol Invest. 2024. PMID: 37563447 Free PMC article. No abstract available.
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value.
Citarella A, Besharat ZM, Trocchianesi S, Autilio TM, Verrienti A, Catanzaro G, Splendiani E, Spinello Z, Cantara S, Zavattari P, Loi E, Romei C, Ciampi R, Pezzullo L, Castagna MG, Angeloni A, Elisei R, Durante C, Po A, Ferretti E. Citarella A, et al. Biomark Res. 2023 Sep 19;11(1):82. doi: 10.1186/s40364-023-00522-4. Biomark Res. 2023. PMID: 37726827 Free PMC article.
PCSK9 inhibitors: a patent review 2018-2023.
Fassi EMA, Citarella A, Albani M, Milano EG, Legnani L, Lammi C, Silvani A, Grazioso G. Fassi EMA, et al. Among authors: citarella a. Expert Opin Ther Pat. 2024 Apr 11:1-17. doi: 10.1080/13543776.2024.2340569. Online ahead of print. Expert Opin Ther Pat. 2024. PMID: 38588538 Review.
84 results